The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sidorov I.V.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Fedorova A.S.

Lomonosov Moscow State University

Konopleva E.I.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Makarova N.P.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Sharlai A.S.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Konovalov D.M.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology;
Russian Medical Academy of Continuous Professional Education

CIC-rearranged sarcoma: a case report and literature review

Authors:

Sidorov I.V., Fedorova A.S., Konopleva E.I., Makarova N.P., Sharlai A.S., Konovalov D.M.

More about the authors

Read: 3280 times


To cite this article:

Sidorov IV, Fedorova AS, Konopleva EI, Makarova NP, Sharlai AS, Konovalov DM. CIC-rearranged sarcoma: a case report and literature review. Russian Journal of Archive of Pathology. 2023;85(3):64‑70. (In Russ.)
https://doi.org/10.17116/patol20238503164

References:

  1. Forés M, Simón-Carrasco L, Ajuria L, Samper N, González-Crespo S, Drosten M, Barbacid M, Jiménez G. A new mode of DNA binding distinguishes Capicua from other HMG-box factors and explains its mutation patterns in cancer. PLoS Genet. 2017;13(3):e1006622. https://doi.org/10.1371/journal.pgen.1006622
  2. Richkind KE, Romansky SG, Finklestein JZ. t(4;19)(q35;q13.1): a recurrent change in primitive mesenchymal tumors? Cancer Genet Cytogenet. 1996;87(1):71-74.  https://doi.org/10.1016/0165-4608(95)00240-5
  3. Kawamura-Saito M, Yamazaki Y, Kaneko K, Kawaguchi N, Kanda H, Mukai H, Gotoh T, Motoi T, Fukayama M, Aburatani H, et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet. 2006;15(13):2125-2137. https://doi.org/10.1093/hmg/ddl136
  4. Yoshimoto M, Graham C, Chilton-MacNeill S, Lee E, Shago M, Squire J, Zielenska M, Somers GR. Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event. Cancer Genet Cytogenet. 2009; 195(1):1-11.  https://doi.org/10.1016/j.cancergencyto.2009.06.015
  5. Italiano A, Sung YS, Zhang L, Singer S, Maki RG, Coindre JM, Antonescu CR. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer. 2012;51(3):207-218.  https://doi.org/10.1002/gcc.20945
  6. Hung YP, Fletcher CD, Hornick JL. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics. Mod Pathol. 2016;29(11):1324-1334. https://doi.org/10.1038/modpathol.2016.140
  7. WHO Classification of Tumours Editorial Board. WHO Classification of Tumours. Soft tissue and bone tumours, 5th ed. Vol. 3. Lyon: IARC; 2020.
  8. Antonescu CR, Owosho AA, Zhang L, Chen S, Deniz K, Huryn JM, Kao YC, Huang SC, Singer S, Tap W, et al. Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol. 2017;41(7):941-949.  https://doi.org/10.1097/PAS.0000000000000846
  9. Gambarotti M, Benini S, Gamberi G, Cocchi S, Palmerini E, Sbaraglia M, Donati D, Picci P, Vanel D, Ferrari S, et al. CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases. Histopathology. 2016;69(4):624-634.  https://doi.org/10.1111/his.12985
  10. Yoshida A, Goto K, Kodaira M, Kobayashi E, Kawamoto H, Mori T, Yoshimoto S, Endo O, Kodama N, Kushima R, et al. CIC-rearranged sarcomas: a study of 20 cases and comparisons with Ewing sarcomas. Am J Surg Pathol. 2016;40(3):313-323.  https://doi.org/10.1097/PAS.0000000000000570
  11. Le Loarer F, Pissaloux D, Watson S, Godfraind C, Galmiche-Rolland L, Silva K, Mayeur L, Italiano A, Michot A, Pierron G, et al. Clinicopathologic features of CIC-NUTM1 sarcomas, a new molecular variant of the family of CIC-fused sarcomas. Am J Surg Pathol. 2019;43(2):268-276.  https://doi.org/10.1097/PAS.0000000000001187
  12. Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP. Ewing sarcoma and Ewing-like tumors. Virchows Arch. 2020;476(1):109-119.  https://doi.org/10.1007/s00428-019-02720-8
  13. Smith SC, Buehler D, Choi EY, McHugh JB, Rubin BP, Billings SD, Balzer B, Thomas DG, Lucas DR, Goldblum JR, et al. CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expression. Mod Pathol. 2015;28(1):57-68.  https://doi.org/10.1038/modpathol.2014.83
  14. Sugita S, Arai Y, Aoyama T, Asanuma H, Mukai W, Hama N, Emori M, Shibata T, Hasegawa T. NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma. Hum Pathol. 2017;65:225-230.  https://doi.org/10.1016/j.humpath.2017.01.012
  15. Sugita S, Arai Y, Tonooka A, Hama N, Totoki Y, Fujii T, Aoyama T, Asanuma H, Tsukahara T, Kaya M, et al. A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma. Am J Surg Pathol. 2014;38(11):1571-1576. https://doi.org/10.1097/PAS.0000000000000286
  16. Sidorov IV, Fedorova AS, Makarova NP, Konopleva EI, Sharlai AS, Panferova AV, Drui AE, Konovalov DM. Sarcoma with BCOR gene alterations (BCOR-ITD) of the L3 vertebra in an 8-year old boy. Pediatric Hematology/Oncology and Immunopathology. 2022;21(3):84-89. (In Russ.). https://doi.org/10.24287/1726-1708-2022-21-3-84-89
  17. Specht K, Sung YS, Zhang L, Richter GH, Fletcher CD, Antonescu CR. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities. Genes Chromosomes Cancer. 2014;53(7):622-633.  https://doi.org/10.1002/gcc.22172
  18. Hung YP, Fletcher CD, Hornick JL. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics. Mod Pathol. 2016;29(11):1324-1334. https://doi.org/10.1038/modpathol.2016.140
  19. Le Guellec S, Velasco V, Pérot G, Watson S, Tirode F, Coindre JM. ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions. Mod Pathol. 2016;29(12):1523-1531. https://doi.org/10.1038/modpathol.2016.155
  20. Siegele B, Roberts J, Black JO, Rudzinski E, Vargas SO, Galambos C. DUX4 immunohistochemistry is a highly sensitive and specific marker for CIC-DUX4 fusion-positive round cell tumor. Am J Surg Pathol. 2017;41(3):423-429.  https://doi.org/10.1097/PAS.0000000000000772
  21. Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell. 2016;164(5):1060-1072. https://doi.org/10.1016/j.cell.2016.01.015
  22. Huang SC, Zhang L, Sung YS, Chen CL, Kao YC, Agaram NP, Singer S, Tap WD, D’Angelo S, Antonescu CR. Recurrent CIC gene abnormalities in angiosarcomas: a molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations. Am J Surg Pathol. 2016;40(5):645-655.  https://doi.org/10.1097/PAS.0000000000000582
  23. Kao YC, Sung YS, Chen CL, Zhang L, Dickson BC, Swanson D, Vaiyapuri S, Latif F, Alholle A, Huang SC, et al. ETV transcriptional upregulation is more reliable than RNA sequencing algorithms and FISH in diagnosing round cell sarcomas with CIC gene rearrangements. Genes Chromosomes Cancer. 2017;56(6):501-510.  https://doi.org/10.1002/gcc.22454
  24. Yoshida A, Arai Y, Kobayashi E, Yonemori K, Ogura K, Hama N, Mukai W, Motoi T, Kawai A, Shibata T, et al. CIC break-apart fluorescence in-situ hybridization misses a subset of CIC-DUX4 sarcomas: a clinicopathological and molecular study. Histopathology. 2017;71(3):461-469.  https://doi.org/10.1111/his.13252

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.